EYPT
Eyepoint Pharmaceuticals Inc
3.70$
-8.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.8% | 97.1% | 96.5% | 91.0% | 89.2% | 91.6% | 90.2% | 88.1% | 85.9% | 90.3% | 86.6% | 82.7% | |
| 83.1% | 79.2% | 82.3% | 28.0% | 26.5% | 23.8% | 23.5% | 23.6% | 29.6% | 28.0% | 27.0% | 48.4% | |
| 85.0% | 93.2% | 90.9% | 86.4% | 84.3% | 88.6% | 87.8% | 84.9% | 81.1% | 84.1% | 77.2% | 79.1% | |
| 0.3% | 0.2% | 0.9% | 0.4% | 0.1% | 0.1% | 0.1% | 0.2% | 0.4% | 0.2% | 0.4% | 0.0% | |
| 2.9% | 1.1% | 1.3% | 1.1% | 0.9% | 0.6% | 0.6% | 0.9% | 0.8% | 0.5% | 0.4% | 0.8% | |
| 63.4% | 25.0% | 24.1% | 29.6% | 27.3% | 19.6% | 17.7% | 18.3% | 20.5% | 15.9% | 20.0% | 27.1% | |
| 39.9% | 17.8% | 19.0% | 19.2% | 16.2% | 11.7% | 11.5% | 11.0% | 12.0% | 10.2% | 13.0% | 18.4% | |
| 0.7% | 0.2% | 0.3% | 0.3% | 0.4% | 0.3% | 0.5% | – | 0.8% | 0.6% | 0.7% | 1.1% | |
| 6.0% | 1.8% | 2.2% | 4.4% | 2.4% | 2.8% | 4.5% | 6.5% | 4.0% | 2.9% | 6.5% | 7.6% | |
| 36.6% | 75.0% | 75.9% | 70.4% | 72.7% | 80.4% | 82.3% | 81.7% | 79.5% | 84.1% | 80.0% | 72.9% | |
| -454.9% | -208.9% | -234.3% | -247.4% | -276.4% | -208.6% | -253.3% | -324.6% | -412.2% | -303.6% | -412.8% | -562.8% | |
| 24.0% | 11.9% | 16.1% | 16.4% | 18.1% | 15.4% | 19.2% | 23.2% | 27.9% | 22.8% | 29.8% | 37.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.